CHWY vs KPTI · P/E 45, rev $12.60B vs rev $68.5M
Chewy Inc (CHWY) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the CHWY and KPTI stock pages for the full models.
Not investment advice.